SCHEMBL30444594

SCHEMBL30444594

O=C1COc2cc(NC(=O)c3cc(NC(=O)c4ccc5nc[nH]c5c4)ccc3O)ccc2N1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.59
▸ NPC1 O15118 5/20 0.59
▸ SMN1; SMN2 Q16637 4/20 0.59
▸ MAPT P10636 4/20 0.59
▸ CYP3A4 P08684 3/20 0.54
▸ CYP19A1 P11511 3/20 0.54
▸ CYP2C9 P11712 2/20 0.54
▸ POLB P06746 4/20 0.49
▸ HTT P42858 1/20 0.49
▸ KMT2A Q03164 4/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ CASP6 P55212 1/20 0.46
▸ CTDSP1 Q9GZU7 1/20 0.46
▸ CYP1A2 P05177 2/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ NAMPT P43490 1/20 0.45
▸ GAA P10253 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18770354 1.00 RAB9A (0.59) RAB9ANPC1SMN1; SMN2MAPTCYP3A4
SCHEMBL14073830 0.85 NPC1 (0.56) RAB9ANPC1SMN1; SMN2MAPTCYP3A4
SCHEMBL18770343 0.81 CYP3A4 (0.80) MAPTCYP3A4CYP19A1CYP2C9POLB
SCHEMBL30445057 0.79 CYP3A4 (0.54) RAB9ANPC1SMN1; SMN2MAPTCYP3A4
SCHEMBL22284857 0.79 CYP3A4 (0.54) RAB9ANPC1SMN1; SMN2MAPTCYP3A4
SCHEMBL14073935 0.78 MAPT (0.64) RAB9ANPC1SMN1; SMN2MAPTCYP3A4
SCHEMBL14073593 0.78 MAPT (0.58) RAB9ANPC1SMN1; SMN2MAPTCYP3A4
SCHEMBL18770360 0.76 CYP3A4 (0.69) RAB9ANPC1SMN1; SMN2MAPTCYP3A4
SCHEMBL14073931 0.76 CYP3A4 (0.56) RAB9ANPC1SMN1; SMN2MAPTCYP3A4
SCHEMBL14073923 0.76 CYP3A4 (0.54) RAB9ANPC1SMN1; SMN2MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3365330-B1 PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 MANGOSUTHU UNIV OF TECHNOLOGY (ZA) 2023-06-07 — — EP disclosed
Send feedback